These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 3187408

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
    Kurth KH, Debruyne FJ, Senge T, Carpentier PJ, Riedl H, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1985; 185B():135-42. PubMed ID: 3898138
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of intravesical Epodyl therapy for superficial bladder cancer.
    Mufti GR, Virdi JS, Hall MH.
    Br J Urol; 1990 Jan; 65(1):32-5. PubMed ID: 2310930
    [Abstract] [Full Text] [Related]

  • 5. [Epodyl treatment of bladder neoplasms].
    Hannestad R, Otnes B.
    Tidsskr Nor Laegeforen; 1976 Jan 10; 96(1):25-7. PubMed ID: 1257948
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of pathologic changes in the urinary epithelium on the absorption of ethoglucide (Epodyl) from the bladder].
    Lunglmayr G, Kratzik C, Mattausch M.
    Wien Klin Wochenschr; 1984 Mar 02; 96(5):182-5. PubMed ID: 6730516
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
    Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C.
    BJU Int; 2006 Dec 02; 98(6):1181-6. PubMed ID: 17125475
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravesical ethoglucid (Epodyl) for treatment of noninvasive bladder cancer (stage Ta).
    Larson A, Fritjofsson A.
    Ups J Med Sci; 1985 Dec 02; 90(2):127-32. PubMed ID: 3909592
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recurrent superficial transitional cell carcinoma of the bladder: adjuvant topical chemotherapy versus immunotherapy. A prospective randomized trial.
    Flamm J, Bucher A, Höltl W, Albrecht W.
    J Urol; 1990 Aug 02; 144(2 Pt 1):260-3. PubMed ID: 2197428
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of Epodyl in aluminium foil cups as a cause of ineffective treatment of non-invasive bladder tumours.
    Larsen J.
    Scand J Urol Nephrol; 1980 Aug 02; 14(3):239-42. PubMed ID: 7209431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.